Serum Market Report 2026
Global Outlook – By Type (Bovine Serum, Fetal bovine serum (FBS), Other Types), By Inactivation Technique (Heat Inactivated, Non-Heat Inactivated), By Application (Biological Products, Research, Cell Culture, Biopharmaceutical Drugs, Vaccine Products, Diagnostic Products, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2030
Serum Market Overview
• Serum market size has reached to $1.56 billion in 2025 • Expected to grow to $2.56 billion in 2030 at a compound annual growth rate (CAGR) of 10.4% • Growth Driver: Increasing Awareness Of Age-Related Skin Issues Fuels Growth In The Serum Market • Market Trend: Quanterix Leads The Serum Market With Lucentad Biomarker Blood-global-market-report" target="_blank">Blood Test For Ultra-Sensitive Alzheimer Detection • North America was the largest region in 2025.What Is Covered Under Serum Market?
Serum refers to the clear and liquid portion of blood that remains after blood cells and clotting proteins have been eliminated. It is used as a supplement to the basal growth medium in cell culture applications. The main types of serum are bovine serum, fetal bovine serum (FBS), and others. Bovine serum refers to a fluid that remains from the entire blood after clotting, which is transparent and yellow. The inactivation techniques include heat inactivated and non-heat inactivated, and various applications include biological products, research, cell culture, biopharmaceutical drugs, vaccine products, diagnostic products and others.
What Is The Serum Market Size and Share 2026?
The serum market size has grown rapidly in recent years. It will grow from $1.56 billion in 2025 to $1.72 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to growth in academic research funding, expansion of cell culture techniques, rising use of bovine serum in laboratories, increase in diagnostic testing volumes, early growth of biopharmaceutical manufacturing.What Is The Serum Market Growth Forecast?
The serum market size is expected to see rapid growth in the next few years. It will grow to $2.56 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to surge in vaccine and biologics production, increasing adoption of precision medicine, expansion of cell-based research pipelines, rising demand for high-purity serum grades, growth in global biopharmaceutical capacity. Major trends in the forecast period include rising demand for serum in cell culture media, shift toward serum quality standardization, growing use of heat-inactivated serum products, expansion of serum applications in vaccine development, increased preference for traceable and certified serum sources.
Global Serum Market Segmentation
1) By Type: Bovine Serum, Fetal bovine serum (FBS), Other Types 2) By Inactivation Technique: Heat Inactivated, Non-Heat Inactivated 3) By Application: Biological Products, Research, Cell Culture, Biopharmaceutical Drugs, Vaccine Products, Diagnostic Products, Other Applications Subsegments: 1) By Bovine Serum: Raw Bovine Serum, Processed Bovine Serum, Fetal Bovine Serum (FBS) 2) By Fetal Bovine Serum (FBS): FBS (Heat-Inactivated), FBS (Non-Heat-Inactivated) 3) By Other Types: Equine Serum, Porcine Serum, Human SerumWhat Is The Driver Of The Serum Market?
The rise in awareness about age-related skin issues is expected to propel the growth of the serum market going forward. Age-related skin issues refer to skin conditions common among aging people, such as wrinkles, facial movement lines and others. Serum treats age-related skin conditions such as dullness, hyperpigmentation, dehydration, wrinkles, and loss of firmness as well as evens out skin tone, lightens it, reduces visible flaws, and leaves skin nourished. For instance, in 2023, according to Cancer Australia, an Australia-based government agency, approximately 8,257 new cases of melanoma of the skin were diagnosed, accounting for 2.6% of all deaths from cancer. Therefore, a rise in awareness about age-related skin issues is driving the growth of the serum industry.Key Players In The Global Serum Market
Major companies operating in the serum market are Merck Group, Thermo Fisher Scientific Inc., Danaher Corp, Corning Incorporated, Sartorius AG, Bio-Techne Corporation, Takara Bio Inc., Atlas Biologicals Inc., Proliant Health & Biologicals, Seracare Life Sciences Inc., Lampire Biological Labs Inc., Altogen Labs, Innovative Research Inc., Lee Biosolutions Inc., Bovogen Biologicals Pty. Ltd., Caisson Labs Inc., Gemini BioProducts Holding Inc., Valley Biomedical Products & Services Inc., Equitech-Bio Inc., Rocky Mountain Biologicals, PAN-Biotech GmbH, BIOWEST SAS, Moregate Biotech, Tissue Culture Biologicals, Kerafast Inc., Access Biologicals LLC, Animal Technologies Inc., Cell Applications Inc., Cell Sciences Inc.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Serum Market Trends and Insights
Major companies operating in the serum market are focused on introducing advanced solutions, such as ultrasensitive biomarker detection, to gain a competitive edge in the market. Ultrasensitive biomarker detection is the ability to detect and measure biomarkers at extremely low concentrations for earlier disease detection. For instance, in July 2023, Quanterix, a US-based company that provides digitizing biomarker analysis, launched the LucentAD Biomarker Blood Test. LucentAD Biomarker Blood Test is a test that measures an isoform of phosphorylated tau protein in plasma and is designed to aid physicians in the diagnosis of Alzheimer's disease in patients. This test uses a serum sample, and the results are interpreted in conjunction with other diagnostic tools. This test improves the accuracy and efficiency of Alzheimer's disease diagnosis, ultimately benefiting patients and healthcare providers.What Are Latest Mergers And Acquisitions In The Serum Market?
In October 2024, Mankind Pharma Ltd., an India-based pharmaceutical company, acquired BSV Group for an undisclosed amount. With this acquisition, Mankind Pharma aims to strengthen its product portfolio, expand its market presence in key therapeutic segments, enhance operational synergies, and drive long-term growth in the Indian pharmaceutical market. BSV Group is an India-based pharmaceutical company specializing in branded and generic formulations across multiple therapeutic areas.
Regional Insights
North America was the largest region in the serum market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Serum Market?
The serum market consists of sales of specialty fetal bovine serum, newborn calf serum, and donor bovine serum. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Serum Market Report 2026?
The serum market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the serum industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Serum Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.72 billion |
| Revenue Forecast In 2030 | $2.56 billion |
| Growth Rate | CAGR of 10.5% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Type, Inactivation Technique, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Merck Group, Thermo Fisher Scientific Inc., Danaher Corp, Corning Incorporated, Sartorius AG, Bio-Techne Corporation, Takara Bio Inc., Atlas Biologicals Inc., Proliant Health & Biologicals, Seracare Life Sciences Inc., Lampire Biological Labs Inc., Altogen Labs, Innovative Research Inc., Lee Biosolutions Inc., Bovogen Biologicals Pty. Ltd., Caisson Labs Inc., Gemini BioProducts Holding Inc., Valley Biomedical Products & Services Inc., Equitech-Bio Inc., Rocky Mountain Biologicals, PAN-Biotech GmbH, BIOWEST SAS, Moregate Biotech, Tissue Culture Biologicals, Kerafast Inc., Access Biologicals LLC, Animal Technologies Inc., Cell Applications Inc., Cell Sciences Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |